Literature DB >> 19513811

Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: assessing responsiveness in a model of statistical process control.

M Lindner1, G Gramer, S F Garbade, P Burgard.   

Abstract

Tetrahydrobiopterin (BH(4)) cofactor loading is a standard procedure to differentiate defects of BH(4) metabolism from phenylalanine hydroxylase (PAH) deficiency. BH(4) responsiveness also exists in PAH-deficient patients with high residual PAH activity. Unexpectedly, single cases with presumed nil residual PAH activity have been reported to be BH(4) responsive, too. BH(4) responsiveness has been defined either by a >or=30% reduction of blood Phe concentration after a single BH(4) dose or by a decline greater than the individual circadian Phe level variation. Since both methods have methodological disadvantages, we present a model of statistical process control (SPC) to assess BH(4) responsiveness. Phe levels in 17 adult PKU patients of three phenotypic groups off diet were compared without and with three different single oral dosages of BH(4) applied in a double-blind randomized cross-over design. Results are compared for >or=30% reduction and SPC. The effect of BH(4) by >or=30% reduction was significant for groups (p < 0.01) but not for dose (p = 0.064), with no interaction of group with dose (p = 0.24). SPC revealed significant effects for group (p < 0.01) and the interaction for group with dose (p < 0.05) but not for dose alone (p = 0.87). After one or more loadings, seven patients would be judged to be BH(4) responsive either by the 30% criterion or by the SPC model, but only three by both. Results for patients with identical PAH genotype were not very consistent within (for different BH(4) doses) and between the two models. We conclude that a comparison of protein loadings without and with BH(4) combined with a standardized procedure for data analysis and decision would increase the reliability of diagnostic results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513811     DOI: 10.1007/s10545-009-1070-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  33 in total

1.  High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002.

Authors:  Caroline Bernegger; Nenad Blau
Journal:  Mol Genet Metab       Date:  2002-12       Impact factor: 4.797

2.  Letter: Variant forms of phenylketonuria.

Authors:  D M Danks; R G Cotton; P Schlesinger
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

3.  Tetrahydrobiopterin responsiveness in patients with phenylketonuria.

Authors:  Belén Pérez-Dueñas; Maria Antonia Vilaseca; Anna Mas; Nilo Lambruschini; Rafael Artuch; Lilian Gómez; Julia Pineda; Alejandra Gutiérrez; Montse Mila; Jaume Campistol
Journal:  Clin Biochem       Date:  2004-12       Impact factor: 3.281

4.  Tetrahydrobiopterin responsiveness in a large series of phenylketonuria patients.

Authors:  J Weglage; M Grenzebach; A von Teeffelen-Heithoff; T Marquardt; R Feldmann; J Denecke; D Gödde; H G Koch
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

5.  Psychosocial aspects in phenylketonuria.

Authors:  J Weglage; B Fünders; K Ullrich; A Rupp; E Schmidt
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

Authors:  Andreas Schulze; Martin Lindner; Dirk Kohlmüller; Katharina Olgemöller; Ertan Mayatepek; Georg F Hoffmann
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

7.  Biopterin responsive phenylalanine hydroxylase deficiency.

Authors:  Reuben Matalon; Richard Koch; Kimberlee Michals-Matalon; Kathryn Moseley; Sankar Surendran; Stephen Tyring; Heidi Erlandsen; Alejandra Gamez; Raymond C Stevens; Anne Romstad; Lisbeth B Møller; Flemming Guttler
Journal:  Genet Med       Date:  2004 Jan-Feb       Impact factor: 8.822

8.  Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment.

Authors:  Harvey Levy; Barbara Burton; Stephen Cederbaum; Charles Scriver
Journal:  Mol Genet Metab       Date:  2007-12       Impact factor: 4.797

Review 9.  The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

Authors:  Nenad Blau; Heidi Erlandsen
Journal:  Mol Genet Metab       Date:  2004-06       Impact factor: 4.797

10.  Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

Authors:  Marcel R Zurflüh; Johannes Zschocke; Martin Lindner; François Feillet; Céline Chery; Alberto Burlina; Raymond C Stevens; Beat Thöny; Nenad Blau
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

View more
  1 in total

1.  Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation.

Authors:  Jytte Bieber Nielsen; Karin E Nielsen; Flemming Güttler
Journal:  J Inherit Metab Dis       Date:  2010-02       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.